Axogen, Inc. announced that it will celebrate the opening of its Axogen Processing Center (APC) with leaders of the Ohio community on June 12, 2024. APC is designed to process Avance Nerve Graft, a regenerative peripheral nerve scaffold indicated for the treatment of peripheral nerve functional deficit and used by surgeons across the U.S. and internationally to surgically repair injured nerves. The facility is located at 913 Industrial Park Dr. in Vandalia, Ohio.

APC is a world-class biologic processing center designed to provide expanded capacity and support the regulatory transition of Avance from a U.S Food and Drug Administration section 361 tissue product to a section 351 biologic. The 107,000 sq. ft.

facility includes ISO14644 clean rooms, internal quality labs, a surgeon and tissue agency training lab, and support systems and redundancies required for high-quality biologic processes. APC provides approximately three times the previous processing capacity and was designed for future growth and expansion. The facility currently employs nearly 100 professionals with plans to increase this number as production scales up.